Showing results (451-460 of 612) with videos related to
Sort By:
Pageof 62
BJUI Compass|August 5, 2026
Vitamin D and adverse pathologic features in patients undergoing radical prostatectomy in the contemporary magnetic resonance imaging-guided management eraSarita Chitjaroen, Kantima Jongjitaree, Varat Woranisarakul, et al.BJUI Compass|August 12, 2026
Postoperative prostate-specific antigen kinetics after holmium laser enucleation of the prostate in men with low-risk prostate cancerHasim Bakbak, Gurpremjit Singh, Ahmad Abdelaziz, et al.BJUI Compass|August 22, 2026
Combining PSA density and imaging data with transcript markers from urinary cells to improve prediction of prostate cancer reclassification in patients on active surveillanceAngelika Borkowetz, Sebastian Gräfe, Jeremy Kwe, et al.BJUI Compass|July 15, 2020
Effect of microsurgical varicocelectomy on semen parameters, serum, and intratesticular testosterone levelsThiago Fernandes Negris Lima, Fabio Stefano Frech, Premal Patel, et al.BJUI Compass|June 5, 2020
Decreasing postoperative opioid use while managing pain: A prospective study of men who underwent scrotal surgeryAubrey B Greer, Libert Ramos, Justin M Dubin, et al.BJUI Compass|April 27, 2022
The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients-First European DataNikhil Vasdev, Alexander Hampson, Samita Agarwal, et al.BJUI Compass|April 27, 2022
Prognostic value of automated bone scan index for predicting overall survival among bone metastatic castration resistant prostate cancer patients treated with radium-223Yasuhide Miyoshi, Sohgo Tsutsumi, Takashi Kawahara, et al.BJUI Compass|April 27, 2022
The utility of magnetic resonance imaging in prostate cancer diagnosis in the Australian settingJia Ying Isaac Tay, Ken Chow, Dominic J Gavin, et al.BJUI Compass|April 27, 2022
Risk factors in the prediction of long-term patency of Resonance metallic ureteric stent in malignant ureteric obstructionBrian S H Ho, Peter K F Chiu, Wayne Lam, et al.BJUI Compass|April 27, 2022
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinomaYoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, et al.Pageof 62